Search

Your search keyword '"Ekanayaka, Ruvan"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Ekanayaka, Ruvan" Remove constraint Author: "Ekanayaka, Ruvan"
22 results on '"Ekanayaka, Ruvan"'

Search Results

2. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

3. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

4. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

8. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

9. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial

10. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

11. Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial

12. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

13. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

14. Management, characteristics and outcomes of patients with acute coronary syndrome in Sri Lanka

16. Leg edema with (S)-amlodipine vs conventional amlodipine given in triple therapy for hypertension: a randomized double blind controlled clinical trial.

21. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

22. Isolated ventricular non-compaction or 'spongy cardiomyopathy'.

Catalog

Books, media, physical & digital resources